Norman Payson - 24 Oct 2022 Form 4 Insider Report for Progyny, Inc. (PGNY)

Role: Director
Signature: /s/ Mark Livingston, Attorney-in-Fact
Issuer symbol: PGNY
Transactions as of: 24 Oct 2022
Net transactions value: $0
Form type: 4
Filing time: 26 Oct 2022, 17:48:01 UTC
Previous filing: 14 Oct 2022
Next filing: 28 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PGNY	Common Stock	Award	$0	+3,480	+40%	$0.000000	12,132	24 Oct 2022	Direct	F1
holding	PGNY	Common Stock						122,493	24 Oct 2022	See footnote	F2
holding	PGNY	Common Stock						338,616	24 Oct 2022	See footnote	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PGNY	Stock Option (Right to Buy)	Award	$0	+15,080		$0.000000	15,080	24 Oct 2022	Common Stock	15,080	$38.22	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs shall vest on May 23, 2023 subject to the Reporting Person continuing to provide service through such date.
F2	The reportable securities are directly held by EVO Eagle, LLC. The Reporting Person shares voting and dispositive power over the securities.
F3	The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust.
F4	The shares subject to the Option shall vest on May 23, 2023, subject to the Reporting Person continuing to provide service through such date.